Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Immusoft
Immusoft
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Immusoft
Total Funding
$9.4 M
Immusoft Summary
Company Summary
Overview
Immusoft is a biotechnology company that develops therapies. It utilizes immune system programming (ISP) by programming B cells to produce therapeutic proteins for rare diseases.
Type
Private
Status
Active
Founded
2009
HQ
Seattle, WA, US
|
view all locations
Website
https://www.immusoft.com
Cybersecurity rating
Sectors
Healthcare
biotech
therapy
Homepage
Linkedin
twitter
Table of Contents
Key People
Locations
Competitors
Key People
Sean Ainsworth,
Chief Executive Officer, Chairman of the Board
Wendell King,
Board Member
Matthew Scholz,
Founder, Board Member
Linkedin
Rob Hayes,
Chief Scientific Officer
Linkedin
and 5 others
Locations
View all
2 locations detected
Seattle, WA
HQ
United States
454 N 34th Street
San Francisco, CA
United States
1700 Owens Street, Unit B
Competitors and Similar Companies
Acorda Therapeutics
Healthcare - Public
Codiak Biosciences
Healthcare - Public
Polyplus-transfection
Healthcare - Private
Right To Care
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top